Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$443K Hold
1,761
0.17% 23
2026
Q1
$383K Sell
1,761
-345
-16% -$76.5K 0.16% 22
2025
Q4
$481K Hold
2,106
0.2% 20
2025
Q3
$488K Buy
2,106
+790
+60% +$161K 0.21% 22
2025
Q2
$244K Hold
1,316
0.12% 28
2025
Q1
$276K Hold
1,316
0.14% 27
2024
Q4
$234K Hold
1,316
0.12% 32
2024
Q3
$260K Hold
1,316
0.13% 29
2024
Q2
$226K Hold
1,316
0.13% 31
2024
Q1
$240K Hold
1,316
0.14% 29
2023
Q4
$204K Buy
+1,316
New +$192K 0.13% 50
2023
Q2
Sell
-1,316
Closed -$210K 48
2023
Q1
$210K Hold
1,316
0.18% 34
2022
Q4
$213K Buy
+1,316
New +$202K 0.2% 42

Other funds holding ABBV

IMPACTfolio's ABBV Position: Q2 2026 in Review

IMPACTfolio held its AbbVie (ABBV) position steady in Q2 2026 at 1,761 shares worth $443K. The position accounts for 0.17% of the portfolio, ranked #23.

IMPACTfolio first reported a position in ABBV in Q4 2022 and has held it in 13 quarters since. The position peaked at $488K in Q3 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • IMPACTfolio held 1,761 shares of AbbVie worth $443K as of Q2 2026.
  • IMPACTfolio left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.17% of IMPACTfolio's portfolio in Q2 2026, its #23 holding.
  • IMPACTfolio first reported a position in AbbVie in Q4 2022 and has held it in 13 quarters since.
  • IMPACTfolio's AbbVie position peaked at $488K in Q3 2025.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on IMPACTfolio's 13F filing for Q2 2026, filed 22 Jul 2026.